Cargando…
Analysis of drug resistance in HIV protease
BACKGROUND: Drug resistance in HIV is the major problem limiting effective antiviral therapy. Computational techniques for predicting drug resistance profiles from genomic data can accelerate the appropriate choice of therapy. These techniques can also be used to select protease mutants for experime...
Autores principales: | Pawar, Shrikant D., Freas, Christopher, Weber, Irene T., Harrison, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196403/ https://www.ncbi.nlm.nih.gov/pubmed/30343664 http://dx.doi.org/10.1186/s12859-018-2331-y |
Ejemplares similares
-
Evolution of drug resistance in HIV protease
por: Shah, Dhara, et al.
Publicado: (2020) -
HIV-1 Protease: Structural Perspectives on Drug Resistance
por: Weber, Irene T., et al.
Publicado: (2009) -
Highly Drug-Resistant HIV-1 Protease Mutant
PRS17 Shows Enhanced Binding to Substrate Analogues
por: Agniswamy, Johnson, et al.
Publicado: (2019) -
Identifying representative drug resistant mutants of HIV
por: Yu, Xiaxia, et al.
Publicado: (2015) -
HIV Protease: Historical Perspective and Current Research
por: Weber, Irene T., et al.
Publicado: (2021)